Aspire Private Capital’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-341
Closed -$30.7K – 449
2024
Q3
$30.7K Sell
341
-1,632
-83% -$137K 0.01% 272
2024
Q2
$155K Buy
1,973
+205
+12% +$16.8K 0.04% 170
2024
Q1
$154K Buy
1,768
+157
+10% +$13.4K 0.04% 166
2023
Q4
$133K Buy
1,611
+21
+1% +$1.6K 0.04% 160
2023
Q3
$125K Buy
1,590
+288
+22% +$24.1K 0.04% 156
2023
Q2
$115K Buy
1,302
+132
+11% +$11.4K 0.04% 148
2023
Q1
$94.4K Buy
1,170
+609
+109% +$49.6K 0.03% 157
2022
Q4
$43.6K Buy
561
+149
+36% +$12.1K 0.02% 205
2022
Q3
$33K Buy
412
+59
+17% +$5.3K 0.01% 238
2022
Q2
$32K Buy
353
+23
+7% +$2.33K 0.01% 240
2022
Q1
$37K Sell
330
-91
-22% -$9.61K 0.01% 233
2021
Q4
$44K Buy
421
+91
+28% +$10.5K 0.01% 227
2021
Q3
$41K Buy
330
+1
+0.3% +$129 0.01% 226
2021
Q2
$41K Sell
329
-11
-3% -$1.38K 0.01% 224
2021
Q1
$40K Buy
340
+316
+1,317% +$37K 0.01% 231
2020
Q4
$3K Hold
24
– – ﹤0.01% 351
2020
Q3
$2K Sell
24
-30
-56% -$3.01K ﹤0.01% 382
2020
Q2
$5K Buy
54
+51
+1,700% +$4.89K ﹤0.01% 229
2020
Q1
$0 Sell
3
-29
-91% -$3.08K ﹤0.01% 390
2019
Q4
$4K Buy
32
+11
+52% +$1.21K ﹤0.01% 318
2019
Q3
$2K Hold
21
– – ﹤0.01% 363
2019
Q2
$2K Hold
21
– – ﹤0.01% 397
2019
Q1
$2K Hold
21
– – ﹤0.01% 441
2018
Q4
$2K Buy
+21
New +$1.96K ﹤0.01% 418

Other funds holding MDT

Aspire Private Capital's MDT Position: Q4 2024 in Review

Aspire Private Capital sold out of Medtronic (MDT) in Q4 2024, closing a stake of 341 shares — an estimated $30.7K sold.

Aspire Private Capital first reported a position in MDT in Q4 2018 and held it in 24 quarters. The position peaked at $155K in Q2 2024. 2,130 funds tracked by Wall St. Rank hold MDT as of Q4 2024.

  • Aspire Private Capital reported no remaining Medtronic position as of Q4 2024 after selling out during the quarter.
  • Aspire Private Capital sold 341 Medtronic shares in Q4 2024, an estimated $30.7K.
  • Aspire Private Capital first reported a position in Medtronic in Q4 2018 and held it in 24 quarters.
  • Aspire Private Capital's Medtronic position peaked at $155K in Q2 2024.
  • 2,130 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.

Based on Aspire Private Capital's 13F filing for Q4 2024, filed 17 Jan 2025.